表紙
市場調查報告書

腦動脈瘤線圈栓塞術設備的全球市場:2019年∼2023年

Global Aneurysm Coiling and Embolization Devices Market 2019-2023

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 823153
出版日期 內容資訊 英文 131 Pages
訂單完成後即時交付
價格
Back to Top
腦動脈瘤線圈栓塞術設備的全球市場:2019年∼2023年 Global Aneurysm Coiling and Embolization Devices Market 2019-2023
出版日期: 2019年03月29日內容資訊: 英文 131 Pages
簡介

動脈瘤線圈和栓塞裝置的技術進步可能會促進未來幾年的市場成長。具有新穎設計和概念的創新設備有望確保設備輸送,血栓形成,安全性和閉塞耐久性。這進一步導致了各種尺寸的多層面,生物惰性,複雜形狀,柔軟和抗拉伸線圈的發展。供應商也增加研發重點,以引入支架的改進,從而推動動脈瘤捲曲和栓塞裝置市場在預測期內的成長。Technavio的分析師預測,到2023年,動脈瘤捲曲和栓塞裝置市場的年複合成長率將超過10%。

本報告提供全球腦動脈瘤線圈栓塞術設備市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

第1章 摘要整理

第2章 報告的範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2018年)
  • 市場規模及預測(2018年∼2023年)

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各產品

  • 市場區隔:各產品
  • 各產品比較:市場規模及預測(2018年∼2023年)
  • 栓塞用線圈
  • 球囊及支架支援線圈
  • 進入及輸送設備
  • 腦血管瘤夾
  • 支流設備
  • 市場機會:各產品

第7章 客戶形勢

第8章 地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2018年∼2023年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

  • 腦血管瘤夾作為神經血管線圈環的替代手段的高需求
  • 對新產品的銷售的興趣高漲
  • 為了提高IA的認識而強化舉措

第12章 業者情勢

  • 概要
  • 創造性破壞狀況

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Acandis GmbH
  • Johnson & Johnson Services, Inc.
  • Medtronic
  • Penumbra, Inc.
  • Stryker
  • Terumo Corporation

第14章 附錄

  • 調查方法
  • 簡稱的清單

第15章 關於TECHNAVIO

目錄
Product Code: IRTNTR31102

About this market

Technological advances in aneurysm coiling and embolization devices are likely to foster the market growth in the upcoming years. Innovative devices with novel designs and concepts are expected to ensure device delivery, thrombogenicity, safety, and occlusion durability. This has further led to the development of multi-dimensional, biologically inert, complex-shaped, soft, and stretch-resistant coils in various sizes. Vendors are also increasing their R&D focus for introducing improvements in their stents, thus, driving the aneurysm coiling and embolization devices market growth during the forecast period. Technavio's analysts have predicted that the aneurysm coiling and embolization devices market will register a CAGR of over 10% by 2023.

Market Overview

The increasing frequency of UIAs detection

One of the growth drivers of the global aneurysm coiling and embolization devices market is the increasing frequency of UIAs detection. The improving detection of UIAs is leading to an increase in demand for neuroendovascular coiling and stenting procedures, which, in turn, is promoting market growth.

Shortage of skilled neurovascular surgeons

One of the challenges in the growth of the global aneurysm coiling and embolization devices market is the shortage of skilled neurovascular surgeons. The growing demand for neurological services and the rapidly rising geriatric population will limit the adoption of aneurysm coiling and embolization devices, which hinders the market growth.

For the detailed list of factors that will drive and challenge the growth of the aneurysm coiling and embolization devices market during 2019-2023, view our report.

Competitive Landscape

The market appears to be moderately fragmented with the presence of several market players. Several vendors are increasingly focusing on R&D of innovative aneurysm coiling and embolization devices. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Embolization coils - Market size and forecast 2018-2023
  • Balloon and stent-assisted coils - Market size and forecast 2018-2023
  • Access and delivery devices - Market size and forecast 2018-2023
  • Aneurysm clips - Market size and forecast 2018-2023
  • Flow diversion devices - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Growing demand for flow diversion as an alternative to
  • neurovascular coiling
  • Increasing focus on new product launches
  • Increasing initiatives to increase awareness of Ias

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Acandis GmbH
  • Johnson & Johnson Services, Inc.
  • Medtronic
  • Penumbra, Inc.
  • Stryker
  • TERUMO CORPORATION

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations

PART 15: EXPLORE TECHNAVIO

List of Exhibits

  • Exhibit 01: Global medical devices market
  • Exhibit 02: Segments of global medical devices market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: Product - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by product
  • Exhibit 19: Embolization coils - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Embolization coils - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Balloon and stent-assisted coils - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Balloon and stent-assisted coils - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Access and delivery devices - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 24: Access and delivery devices - Year-over-year growth 2019-2023 (%)
  • Exhibit 25: Aneurysm clips - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 26: Aneurysm clips - Year-over-year growth 2019-2023 (%)
  • Exhibit 27: Flow diversion devices - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 28: Flow diversion devices - Year-over-year growth 2019-2023 (%)
  • Exhibit 29: Market opportunity by product
  • Exhibit 30: Customer landscape
  • Exhibit 31: Market share by geography 2018-2023 (%)
  • Exhibit 32: Geographic comparison
  • Exhibit 33: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 36: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 37: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 38: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 39: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 40: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 41: Health expenditure between 2005 and 2015 (% of GDP)
  • Exhibit 42: Key leading countries
  • Exhibit 43: Market opportunity
  • Exhibit 44: Impact of drivers and challenges
  • Exhibit 45: Vendor landscape
  • Exhibit 46: Landscape disruption
  • Exhibit 47: Vendors covered
  • Exhibit 48: Vendor classification
  • Exhibit 49: Market positioning of vendors
  • Exhibit 50: Acandis GmbH - Vendor overview
  • Exhibit 51: Acandis GmbH - Product segments
  • Exhibit 52: Acandis GmbH - Organizational developments
  • Exhibit 53: Acandis GmbH - Key offerings
  • Exhibit 54: Acandis GmbH - Key customers
  • Exhibit 55: Johnson & Johnson Services, Inc. - Vendor overview
  • Exhibit 56: Johnson & Johnson Services, Inc. - Business segments
  • Exhibit 57: Johnson & Johnson Services, Inc. - Organizational developments
  • Exhibit 58: Johnson & Johnson Services, Inc. - Geographic focus
  • Exhibit 59: Johnson & Johnson Services, Inc. - Segment focus
  • Exhibit 60: Johnson & Johnson Services, Inc. - Key offerings
  • Exhibit 61: Johnson & Johnson Services, Inc. - Key customers
  • Exhibit 62: Medtronic - Vendor overview
  • Exhibit 63: Medtronic - Business segments
  • Exhibit 64: Medtronic - Organizational developments
  • Exhibit 65: Medtronic - Geographic focus
  • Exhibit 66: Medtronic - Segment focus
  • Exhibit 67: Medtronic - Key offerings
  • Exhibit 68: Medtronic - Key customers
  • Exhibit 69: Penumbra, Inc. - Vendor overview
  • Exhibit 70: Penumbra, Inc. - Product segments
  • Exhibit 71: Penumbra, Inc. - Organizational developments
  • Exhibit 72: Penumbra, Inc. - Geographic focus
  • Exhibit 73: Penumbra, Inc. - Segment focus
  • Exhibit 74: Penumbra, Inc. - Key offerings
  • Exhibit 75: Penumbra, Inc. - Key customers
  • Exhibit 76: Stryker - Vendor overview
  • Exhibit 77: Stryker - Business segments
  • Exhibit 78: Stryker - Organizational developments
  • Exhibit 79: Stryker - Geographic focus
  • Exhibit 80: Stryker - Segment focus
  • Exhibit 81: Stryker - Key offerings
  • Exhibit 82: Stryker - Key customers
  • Exhibit 83: TERUMO CORPORATION - Vendor overview
  • Exhibit 84: TERUMO CORPORATION - Business segments
  • Exhibit 85: TERUMO CORPORATION - Organizational developments
  • Exhibit 86: TERUMO CORPORATION - Geographic focus
  • Exhibit 87: TERUMO CORPORATION - Segment focus
  • Exhibit 88: TERUMO CORPORATION - Key offerings
  • Exhibit 89: TERUMO CORPORATION - Key customers
  • Exhibit 90: Validation techniques employed for market sizing
Back to Top